TSCAN THERAPEUTICS INC
TCRXNASDAQ🏆 #4742 by market capEarnings Nov 11US Equity
$0.20▲ $0.01 (+3.59%)
🌅 Pre-market$0.20▲ 1.81%Regular close · extended-hours price shownTrack TCRX
Get earnings, price moves & breaking news on Telegram
24h▲ 3.6%
7d▼ 9.8%
14d▼ 16.4%
30d▼ 37.8%
ytd▼ 80.0%
1y▼ 89.6%
🏦Market Cap
$13M
Small Cap
📈Revenue Growth (YoY)
2.1%
Slowing
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
1.8x
Cheap
Otter Score
—
Insufficient data
TSCAN THERAPEUTICS INC
TCRXAnalyst Ratings
Price
$0.1989
Total
8
Raised
0
Lowered
4
Avg PT
$1.00
H / L
$1 / $1
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Downgraded | Buy → Neutral | 2026-09-08 | — | — |
Wedbush | Downgraded | Outperform → Neutral | 2026-09-03 | $1.00 | +402.80% |
Needham | Downgraded | Buy → Hold | 2026-09-02 | — | — |
BTIG | Downgraded | Buy → Neutral | 2025-11-04 | $12.00 | +5933.20% |
Barclays | Reiterated | Overweight | 2025-03-07 | $3.00 | +1408.30% |
Cowen & Co. | Reiterated | Outperform | 2021-08-13 | — | — |
Jefferies | Reiterated | Buy | 2021-08-10 | — | — |
Morgan Stanley | Reiterated | Overweight | 2021-08-10 | — | — |
Institution
HC Wainwright & Co.
Downgraded · Buy → Neutral · 2026-09-08
—
—
Wedbush
Downgraded · Outperform → Neutral · 2026-09-03
$1.00
+402.80%
Needham
Downgraded · Buy → Hold · 2026-09-02
—
—
BTIG
Downgraded · Buy → Neutral · 2025-11-04
$12.00
+5933.20%
Barclays
Reiterated · Overweight · 2025-03-07
$3.00
+1408.30%
Cowen & Co.
Reiterated · Outperform · 2021-08-13
—
—
Jefferies
Reiterated · Buy · 2021-08-10
—
—
Morgan Stanley
Reiterated · Overweight · 2021-08-10
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space